Steerable Surgical Device Technology Company Verix Health Secures $8 Million In Funding

By Dan Anderson ● October 28, 2019
  • Verix Health (formerly known as Greppo Technologies) announced it raised $8 million in Series A funding led by Ajax Health

Verix Health (formerly known as Greppo Technologies) announced that it has raised $8 million in Series A funding led by Ajax Health with participation from Aperture Venture Partners and Western Technology Investment. And Verix Health is developing a portfolio of steerable devices enabling minimally invasive delivery of diagnostic and therapeutic tools for solid-organ cancers. This capital will be used for funding ongoing R&D activities and preparing the product line for commercialization. 

“From the beginning, our vision has been to create a platform capable of enabling advanced diagnosis and therapy for a spectrum of diseases,” said Sasha Schrode, CEO of Verix Health. “We are honored to have the support of Ajax Health, Aperture and WTI to help us achieve our important mission. Through this collaboration, we believe we are making significant progress toward innovating devices that will have a profound impact on patients.”

“Verix Health is positioned to address a critical unmet need—navigation of complex anatomies to enable diagnostic and therapeutic interventions in oncology,” added Duke Rohlen, Chairman and CEO of Ajax Health. “We are excited to join the team and help the company realize its potential for patient benefit and value creation.”

Along with the funding, Ajax Health is also bringing multiple executives to the Verix Health management team, including Rohlen as Executive Chairman, Doug Koo as CFO, and Joe Koblish as CTO. Rohlen worked in top executive roles and led successful exits at EPIX Therapeutics, Spirox, CV Ingenuity, and FoxHollow Technologies. And Rohlen is joined at Ajax Health by Dr. Aftab Kherani — who serves as the company’s interim CMO.

Verix Health is building a suite of actively steerable surgical devices enabling minimally invasive diagnosis and treatment of lesions in difficult-to-access anatomies. Professor Mark Yim, PhD and PCI Ventures at the University of Pennsylvania founded Verix Health and it was incubated at the Pennovation Center in Philadelphia. The company is now headquartered in Santa Clara, California.